Raymond James & Associates Decreases Stock Position in Integral Ad Science Holding Corp. (NASDAQ:IAS)

Raymond James & Associates lessened its stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IASFree Report) by 7.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 40,535 shares of the company’s stock after selling 3,278 shares during the period. Raymond James & Associates’ holdings in Integral Ad Science were worth $583,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. grew its position in Integral Ad Science by 15.2% in the 3rd quarter. Vanguard Group Inc. now owns 7,325,778 shares of the company’s stock valued at $87,104,000 after acquiring an additional 966,280 shares during the last quarter. TimesSquare Capital Management LLC grew its position in shares of Integral Ad Science by 32.2% during the 3rd quarter. TimesSquare Capital Management LLC now owns 2,486,748 shares of the company’s stock worth $29,567,000 after buying an additional 605,824 shares in the last quarter. Jacobs Levy Equity Management Inc. grew its position in shares of Integral Ad Science by 88.4% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 1,167,392 shares of the company’s stock worth $13,880,000 after buying an additional 547,856 shares in the last quarter. Qube Research & Technologies Ltd bought a new stake in Integral Ad Science during the third quarter valued at about $5,548,000. Finally, CenterBook Partners LP boosted its position in Integral Ad Science by 174.7% during the third quarter. CenterBook Partners LP now owns 454,995 shares of the company’s stock valued at $5,410,000 after purchasing an additional 289,341 shares in the last quarter. Hedge funds and other institutional investors own 95.78% of the company’s stock.

Wall Street Analysts Forecast Growth

IAS has been the topic of a number of recent research reports. Piper Sandler dropped their price objective on Integral Ad Science from $20.00 to $18.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 28th. Truist Financial dropped their price objective on Integral Ad Science from $26.00 to $17.00 and set a “buy” rating on the stock in a research report on Wednesday, February 28th. BMO Capital Markets dropped their price objective on Integral Ad Science from $18.00 to $16.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 28th. Raymond James downgraded Integral Ad Science from a “strong-buy” rating to an “outperform” rating and dropped their price objective for the company from $20.00 to $16.00 in a research report on Wednesday, February 28th. Finally, Bank of America began coverage on Integral Ad Science in a research report on Thursday, January 11th. They set a “buy” rating and a $19.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, Integral Ad Science currently has a consensus rating of “Moderate Buy” and an average price target of $17.58.

View Our Latest Report on IAS

Insider Buying and Selling

In other Integral Ad Science news, CEO Lisa Utzschneider sold 30,407 shares of the business’s stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $10.05, for a total value of $305,590.35. Following the completion of the transaction, the chief executive officer now directly owns 188,678 shares of the company’s stock, valued at $1,896,213.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Integral Ad Science news, CFO Tania Secor sold 17,999 shares of the business’s stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $10.05, for a total value of $180,889.95. Following the completion of the transaction, the chief financial officer now directly owns 239,174 shares of the company’s stock, valued at $2,403,698.70. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Lisa Utzschneider sold 30,407 shares of the business’s stock in a transaction that occurred on Monday, April 8th. The shares were sold at an average price of $10.05, for a total value of $305,590.35. Following the completion of the transaction, the chief executive officer now directly owns 188,678 shares of the company’s stock, valued at $1,896,213.90. The disclosure for this sale can be found here. Insiders sold 80,195 shares of company stock valued at $876,562 over the last quarter. 2.00% of the stock is currently owned by company insiders.

Integral Ad Science Trading Down 0.9 %

Integral Ad Science stock opened at $9.47 on Friday. The company has a quick ratio of 3.21, a current ratio of 3.21 and a debt-to-equity ratio of 0.17. Integral Ad Science Holding Corp. has a 52 week low of $8.92 and a 52 week high of $20.88. The company has a market capitalization of $1.51 billion, a price-to-earnings ratio of 236.81, a price-to-earnings-growth ratio of 1.66 and a beta of 1.60. The stock has a 50-day moving average price of $10.76 and a 200 day moving average price of $12.95.

Integral Ad Science (NASDAQ:IASGet Free Report) last released its earnings results on Tuesday, February 27th. The company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.03. Integral Ad Science had a return on equity of 0.83% and a net margin of 1.53%. The firm had revenue of $134.30 million during the quarter, compared to the consensus estimate of $131.27 million. During the same quarter in the previous year, the company posted $0.07 earnings per share. The company’s revenue was up 14.4% compared to the same quarter last year. Sell-side analysts anticipate that Integral Ad Science Holding Corp. will post 0.16 EPS for the current year.

About Integral Ad Science

(Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Featured Articles

Want to see what other hedge funds are holding IAS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integral Ad Science Holding Corp. (NASDAQ:IASFree Report).

Institutional Ownership by Quarter for Integral Ad Science (NASDAQ:IAS)

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.